Eli Lilly (NYSE:LLY): This fall Non-GAAP EPS of $2.75 beats by $0.36; GAAP EPS of $2.32 beats by $0.26.
Income of $7.44B (+21.8% Y/Y) beats by $170M.
Gross margin of 76.9% vs. 78% consensus.
FY21 Steerage: 2021 GAAP EPS steerage lowered to be within the vary of $7.10 to $7.75 to replicate current enterprise improvement actions, and Adj. EPS reaffirmed to be within the vary of $7.75 to $8.40.
Income between $26.5 billion and $28.0 billion, together with an estimated $1 billion to $2 billion of income from COVID-19 therapies.
FY21 Income consensus of $27.60B, Non-GAAP EPS consensus of $8.19.
Shares -0.3% PM.
Press Launch
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %
Average Rating